Skip to main content
Top
Published in: BMC Nephrology 1/2018

Open Access 01-12-2018 | Research article

Safety and adequacy of percutaneous kidney biopsy performed by nephrology trainees

Authors: Vittoria Esposito, Giulia Mazzon, Paola Baiardi, Massimo Torreggiani, Luca Semeraro, Davide Catucci, Marco Colucci, Alice Mariotto, Fabrizio Grosjean, Giacomo Bovio, Ciro Esposito

Published in: BMC Nephrology | Issue 1/2018

Login to get access

Abstract

Background

Recently there has been a progressive loss of specialty related skills for nephrologists. Among the skills we find the kidney biopsy that has a central role in diagnosis of renal parenchymal disease. One of the causes might be the belief that the kidney biopsy should be performed only in larger Centers which can rely on the presence of a renal pathologist and on nephrologists with a large experience. This trend may increase in the short term procedural safety but may limit the chance of in training nephrologists to become confident with the technique.

Methods

We evaluated renal biopsies performed from May 2002 to October 2016 in our Hospital, a mid-sized facility to determine whether the occurrence of complications would be comparable to those reported in literature and whether the increase in the number of biopsy performing physicians including nephrology fellows which took place since January 2012, after our Nephrology Unit became academic, would be associated to an increase of complications or a reduction of diagnostic power of renal biopsies. Three hundred thirty seven biopsies were evaluated. Patients underwent ultrasound guided percutaneous renal biopsy using a 14 G core needle loaded on a biopsy gun. Observation lasted for 24 h, we evaluated hemoglobin levels 6 and 24 h and kidney ultrasound 24 h after the biopsy.

Results

Complications occurred in 18.7% of patients, of these only 1,2% were major complications. Complications were more common in female (28%) compared to male patients (14,8%) (p = 0.004). We found no correlation between diagnosis, kidney function and complication rates; hypertension was not associated to a higher risk in complications. The increase of biopsy performing personnel was not associated to an increase in complication rates (18,7% both pre and post 2012) or with an increase of major complications (1.2% vs 1,2%).

Conclusions

Kidney biopsy can be safely performed in mid-sized hospitals. Safety and adequacy are guaranteed even if the procedure is performed by a larger number of less experienced nephrologists as long as under tutor supervision, thus kidney biopsy should become an integral part of a nephrology fellow training allowing more widespread diffusion of this technique.
Literature
1.
2.
go back to reference Lane CA, Healy C, Ho MT, Pearson SA, Brown MA. How to attract a nephrology trainee:quantitative questionnaire results. Nephrology. 2008;13:116–23.CrossRefPubMed Lane CA, Healy C, Ho MT, Pearson SA, Brown MA. How to attract a nephrology trainee:quantitative questionnaire results. Nephrology. 2008;13:116–23.CrossRefPubMed
3.
go back to reference Daniels MN, Maynard S, Porter I, Kincaid H, Jain D, Aslam N. Career interest and perceptions of nephrology: a repeated cross-sectional survey of internal medicine residents. PLoS One. 2017;12(2):e0172167.CrossRefPubMedPubMedCentral Daniels MN, Maynard S, Porter I, Kincaid H, Jain D, Aslam N. Career interest and perceptions of nephrology: a repeated cross-sectional survey of internal medicine residents. PLoS One. 2017;12(2):e0172167.CrossRefPubMedPubMedCentral
4.
go back to reference Shah HH, Jhaveri KD, Sparks MA, Mattana J. Career choice selection and satisfaction among US adult nephrology fellows. Clin J Am Soc Nephrol. 2012;7:1513–20.CrossRefPubMed Shah HH, Jhaveri KD, Sparks MA, Mattana J. Career choice selection and satisfaction among US adult nephrology fellows. Clin J Am Soc Nephrol. 2012;7:1513–20.CrossRefPubMed
5.
go back to reference Cameron JS, Hicks J. The introduction of renal biopsy into nephrology from 1901 to 1961: a paradigm of the forming of nephrology by technology. Am J Nephrol. 1997;17:347–58.CrossRefPubMed Cameron JS, Hicks J. The introduction of renal biopsy into nephrology from 1901 to 1961: a paradigm of the forming of nephrology by technology. Am J Nephrol. 1997;17:347–58.CrossRefPubMed
6.
go back to reference Hwang HS, Lee SY, Kang SH, Jung BH, Hyoung BJ, Jeon YJ, Choi BS, Park CW, Yang CW, Kim Y. Specimen adequacy and safety of percutaneous ultrasound-guided native kidney biopsies performed by short-term trained nephrology fellows. Korean J Nephrol. 2010;29:215–23. Hwang HS, Lee SY, Kang SH, Jung BH, Hyoung BJ, Jeon YJ, Choi BS, Park CW, Yang CW, Kim Y. Specimen adequacy and safety of percutaneous ultrasound-guided native kidney biopsies performed by short-term trained nephrology fellows. Korean J Nephrol. 2010;29:215–23.
7.
go back to reference Shidham GA. Clinical risk factors associated with bleeding after native kidney biopsy. Nephrology. 2005;10:305–10.CrossRefPubMed Shidham GA. Clinical risk factors associated with bleeding after native kidney biopsy. Nephrology. 2005;10:305–10.CrossRefPubMed
8.
go back to reference Corapi KM, Chen JL, Balk EM, Gordon CE. Bleeding complications of native kidney biopsy: a systematic review and meta-analysis. Am J Kidney Dis. 2012;60:62–73.CrossRefPubMed Corapi KM, Chen JL, Balk EM, Gordon CE. Bleeding complications of native kidney biopsy: a systematic review and meta-analysis. Am J Kidney Dis. 2012;60:62–73.CrossRefPubMed
9.
go back to reference Song JH, Cronan JJ. Percutaneous biopsy in diffuse renal disease: comparison of 18- and 14-gauge automated biopsy devices. J Vasc Interv Radiol. 1998;9:651–5.CrossRefPubMed Song JH, Cronan JJ. Percutaneous biopsy in diffuse renal disease: comparison of 18- and 14-gauge automated biopsy devices. J Vasc Interv Radiol. 1998;9:651–5.CrossRefPubMed
10.
go back to reference Nicholson ML, Wheatley TJ, Doughman TM, White SA, Morgan JD, Veitch PS, Furness PN. A prospective randomized trial of three different sizes of core-cutting needle for renal transplant biopsy. Kidney Int. 2000;58:390–5.CrossRefPubMed Nicholson ML, Wheatley TJ, Doughman TM, White SA, Morgan JD, Veitch PS, Furness PN. A prospective randomized trial of three different sizes of core-cutting needle for renal transplant biopsy. Kidney Int. 2000;58:390–5.CrossRefPubMed
11.
go back to reference Whittier WL, Korbet SM. Timing of complications in percutaneous renal biopsy. J Am Soc Nephrol. 2004;15:142–7.CrossRefPubMed Whittier WL, Korbet SM. Timing of complications in percutaneous renal biopsy. J Am Soc Nephrol. 2004;15:142–7.CrossRefPubMed
12.
go back to reference Chunduri S, Whittier WL, Korbet SM. Adequacy and complication rates with 14- vs. 16-gauge automated needles in percutaneous renal biopsy of native kidneys. Semin Dial. 2015;28:E11–4.CrossRefPubMed Chunduri S, Whittier WL, Korbet SM. Adequacy and complication rates with 14- vs. 16-gauge automated needles in percutaneous renal biopsy of native kidneys. Semin Dial. 2015;28:E11–4.CrossRefPubMed
13.
go back to reference Manno C, Strippoli GFM, Arnesano L, Bonifati C, Campobasso N, Gesualdo L, Schena FP. Predictors of bleeding complications in percutaneous ultrasound-guided renal biopsy. Kidney Int. 2004;66:1570–7.CrossRefPubMed Manno C, Strippoli GFM, Arnesano L, Bonifati C, Campobasso N, Gesualdo L, Schena FP. Predictors of bleeding complications in percutaneous ultrasound-guided renal biopsy. Kidney Int. 2004;66:1570–7.CrossRefPubMed
14.
go back to reference Korbet SM, Volpini KC, Whittier WL. Percutaneous renal biopsy of native kidneys: a single-center experience of 1,055 biopsies. Am J Nephrol. 2014;39:153–62.CrossRefPubMed Korbet SM, Volpini KC, Whittier WL. Percutaneous renal biopsy of native kidneys: a single-center experience of 1,055 biopsies. Am J Nephrol. 2014;39:153–62.CrossRefPubMed
15.
go back to reference Shidham GB, Siddiqi N, Beres JA, Logan B, Nagaraja HN, Shidham SG, Piering WF. Clinical risk factors associated with bleeding after native kidney biopsy. Nephrology (Carlton). 2005;10:305–10.CrossRef Shidham GB, Siddiqi N, Beres JA, Logan B, Nagaraja HN, Shidham SG, Piering WF. Clinical risk factors associated with bleeding after native kidney biopsy. Nephrology (Carlton). 2005;10:305–10.CrossRef
16.
go back to reference Eiro M, Katoh T, Watanabe T. Risk factors for bleeding complications in percutaneous renal biopsy. Clin Exp Nephrol. 2005;9:40–5.CrossRefPubMed Eiro M, Katoh T, Watanabe T. Risk factors for bleeding complications in percutaneous renal biopsy. Clin Exp Nephrol. 2005;9:40–5.CrossRefPubMed
17.
go back to reference Prasad N, Kumar S, Manjunath R, Bhadauria D, Kaul A, Sharma RK, Gupta A, Lal H, Jain M, AgrawaL V. Real-time ultrasound –guided percutaneous renal biopsy with needle guide by nephrologists decreases post-biopsy complications. Clin Kidney J. 2015;2:151–6.CrossRef Prasad N, Kumar S, Manjunath R, Bhadauria D, Kaul A, Sharma RK, Gupta A, Lal H, Jain M, AgrawaL V. Real-time ultrasound –guided percutaneous renal biopsy with needle guide by nephrologists decreases post-biopsy complications. Clin Kidney J. 2015;2:151–6.CrossRef
18.
go back to reference Clark E, Barsuk JH, Karpinski J, McQuillan R. Achieving procedural competence during nephrology fellowship training: current requirements and educational research. Clin J Am Soc Nephrol. 2016;11:2244–9.CrossRefPubMedPubMedCentral Clark E, Barsuk JH, Karpinski J, McQuillan R. Achieving procedural competence during nephrology fellowship training: current requirements and educational research. Clin J Am Soc Nephrol. 2016;11:2244–9.CrossRefPubMedPubMedCentral
19.
go back to reference Walker PD, Cavallo T, Bonsib SM, Ad Hoc committee on Renal Biopsy Guidelines of the Renal Pathology Society. Practice guidelines for the renal biopsy. Mod Pathol. 2004;17:1555–63.CrossRefPubMed Walker PD, Cavallo T, Bonsib SM, Ad Hoc committee on Renal Biopsy Guidelines of the Renal Pathology Society. Practice guidelines for the renal biopsy. Mod Pathol. 2004;17:1555–63.CrossRefPubMed
20.
go back to reference Hogan JJ, Mocanu M, Berns JS. The native kidney biopsy:update and evidence for best practice. Clin J Am Soc Nephrol. 2016;11:354–62.CrossRefPubMed Hogan JJ, Mocanu M, Berns JS. The native kidney biopsy:update and evidence for best practice. Clin J Am Soc Nephrol. 2016;11:354–62.CrossRefPubMed
21.
go back to reference Dawoud D, Lyndon W, Mrug S, Bissler JJ, Mrug M. Impact of ultrasound-guided kidney biopsy simulation on trainee confidence and biopsy outcomes. Am J Nephrol. 2012;36:570–4.CrossRefPubMedPubMedCentral Dawoud D, Lyndon W, Mrug S, Bissler JJ, Mrug M. Impact of ultrasound-guided kidney biopsy simulation on trainee confidence and biopsy outcomes. Am J Nephrol. 2012;36:570–4.CrossRefPubMedPubMedCentral
22.
go back to reference Chung S, Koh ES, Kim SJ, Yoon HE, Park CW, Chang YS, Shin SJ. Safety and tissue yield for percutaneous native kidney biopsy according to practitioner and ultrasoud technique. BMC Nephrol. 2014;15:96.CrossRefPubMedPubMedCentral Chung S, Koh ES, Kim SJ, Yoon HE, Park CW, Chang YS, Shin SJ. Safety and tissue yield for percutaneous native kidney biopsy according to practitioner and ultrasoud technique. BMC Nephrol. 2014;15:96.CrossRefPubMedPubMedCentral
Metadata
Title
Safety and adequacy of percutaneous kidney biopsy performed by nephrology trainees
Authors
Vittoria Esposito
Giulia Mazzon
Paola Baiardi
Massimo Torreggiani
Luca Semeraro
Davide Catucci
Marco Colucci
Alice Mariotto
Fabrizio Grosjean
Giacomo Bovio
Ciro Esposito
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2018
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-017-0796-y

Other articles of this Issue 1/2018

BMC Nephrology 1/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.